{"filings":[{"id":99219,"accession_number":"0001493152-26-021512","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2026-05-06T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Milestone Scientific dismisses auditor CBIZ; engages Grassi & Co. effective May 15, 2026","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CBIZ CPAs' 2025 audit report included a going concern explanatory paragraph about substantial doubt.","No disagreements or reportable events during 2025 or interim period through April 30, 2026.","New auditor Grassi & Co. engaged for fiscal year ending Dec 31, 2026, approved by Audit Committee.","CBIZ had become auditor in April 2025 via acquisition of Marcum LLP's attest business."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":99218,"accession_number":"0001493152-26-021506","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2026-05-06T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Milestone Scientific reprices CEO & SVP options and proposes PRSU plan with up to 17.2M shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO Eric Hines and SVP Jason Papes surrender options at $0.46-$0.50 for new options at $0.31 exercise price.","New options vest 500K shares immediately (accelerated from 200K) and 750K on each of next two anniversaries.","PRSU sub-plan subject to stockholder approval; aggregate pool of 17,234,635 shares if all five milestones met.","PRSU grants of 5.17M shares to Hines and 3.02M each to Harcum and Papes (total 11.2M shares).","Performance milestones: LTM net sales >$11M/$13M/$15M, market cap >$50M, qualified acquisition with >$10M revenue."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":99217,"accession_number":"0001493152-26-018231","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2026-04-21T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Milestone Scientific closes $2.15M private placement of units at $0.27/unit","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issued 7,962,963 units, each consisting of one common share and one warrant (exercise $0.3375, 3-yr term).","Gross proceeds $2.15M: $1.80M cash + $0.351M conversion of director/officer bridge notes; no placement agent.","Directors and officers purchased $150K cash units and converted $351K bridge notes on same terms as investors.","Proceeds for working capital and past due payables; additional $2.69M if warrants fully exercised.","12-month lock-up agreements for directors, officers, and certain stockholders."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":99216,"accession_number":"0001493152-26-014892","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2026-04-02T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Milestone Scientific amends MOU with Innovest/BP4, extends lock-up deadline to April 17, 2026","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Amendment extends deadline for BP4 lock-up agreements to April 17, 2026, with automatic extension to May 1 if a capital raise is underway.","Qualified Offering redefined: one or more offerings within 45 days with gross proceeds of at least $900K and up to 19.99% of shares (~$2.3M at $0.29/sh).","Company agrees to pay BP4 an additional $27,500 within 5 business days for disbursements, subject to $100K aggregate cap.","Other Locked-Up Parties expanded to include directors, officers, and United Systems and its affiliates."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":115101,"accession_number":"0001493152-26-009581","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2026-03-11T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Milestone Scientific increases authorized common shares from 100M to 125M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Certificate of Amendment filed with Delaware Secretary of State on March 10, 2026, effective upon filing.","Stockholders approved the increase at the December 18, 2025 annual meeting.","All other terms of the Restated Certificate of Incorporation remain unchanged.","Increase in authorized shares may be used for future financing or corporate purposes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":115099,"accession_number":"0001493152-26-005041","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K/A","filed_at":"2026-02-04T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"MLSS enters amended MoU locking up ~8.9M BP4 shares for 12 months post-$2.5M qualified offering","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["BP4 (controlled by Innovest) agrees to lock up ~8.9M shares of MLSS for 12 months after a Qualified Offering raising at least $2.5M.","BP4 can distribute shares early if MLSS stock exceeds $0.50, $0.70, $0.90 for 10 consecutive days (33.33% each tranche).","Other parties (directors, officers, Leonard Osser, United Systems) must also enter lock-up agreements.","Company pays up to $100k in fees, including $32k within 5 days. Standstill until Jan 31 (extendable to Feb 15).","Lock-up and MoU conditional on BP4 shareholder approval by January 25, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":115100,"accession_number":"0001493152-26-002934","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2026-01-20T23:59:59+00:00","items":["1.01"],"status":"ready","headline":"Milestone Scientific enters lock-up agreement with 11.31% shareholder BP4 after $2.5M offering","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["BP4 S.r.l., holder of 11.31% of MLSS common stock, agrees to 12-month lock-up after $2.5M offering.","Lock-up release tranches: 33.33% at $0.50, additional 33.3% at $0.70, final 33.3% at $0.90 (10 consecutive trading days).","BP4 shareholders approved the MOU on January 15, 2026.","Customary underwriter exceptions apply; distributions to BP4 shareholders permitted upon price triggers."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":131492,"accession_number":"0001493152-25-029067","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2025-12-23T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Milestone Scientific shareholders elect six directors, approve share increase to 125M, ratify auditors","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All six incumbent directors re-elected with average 92.84% votes for; Benedicta Casamento got 85.92%.","Amendment to increase authorized common stock from 100M to 125M shares passed with 96.18% of votes cast.","Ratification of CBIZ CPA P.C. as independent auditors for FY 2025 approved with 98.38% of votes cast (excluding broker non-votes).","Voter turnout was 61.53% (48.38M of 78.63M outstanding shares)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":131491,"accession_number":"0001493152-25-022357","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2025-11-13T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Leonard A. Osser resigns from board, remains employed and consulting","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Leonard A. Osser resigned as director effective November 7, 2025.","Osser will continue involvement via employment agreement and consulting with U.S. Asian Consulting Group, LLC.","No immediate replacement for board seat disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":131490,"accession_number":"0001493152-25-017919","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2025-10-14T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Milestone Scientific receives NYSE American delisting notice for non-compliance","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received NYSE American letter on Oct 8, 2025, citing non-compliance with Sections 1003(a)(ii) and (iii) of the Company Guide.","Must submit a plan of compliance by November 7, 2025, to regain listing.","If plan accepted, company remains listed subject to periodic review; if not, delisting procedures may begin.","Failure to comply by April 8, 2027, or lack of progress will trigger delisting.","Management is pursuing options and intends to submit compliance plan by deadline."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":148079,"accession_number":"0001437749-25-024900","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2025-08-05T23:59:59+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"Milestone Scientific appoints Eric Hines as CEO; compensation includes options for 2M shares","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Eric Hines named President and CEO effective July 31, 2025; also appointed to the Board.","Base salary $15K/month through Dec 2025, then $25K/month starting Jan 2026 if employment continues.","Signing bonus options for 2,000,000 shares; 10% vest immediately, 90% in three equal annual installments.","Hines previously President of North America at Ex Libris, scaling revenue from ~$50M to over $100M.","Press release cites recent Medicare Part B payment rate assignments and commercial insurance reimbursements for CompuFlo."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.62,"calibrated_materiality_score":0.62,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":166827,"accession_number":"0001437749-25-017562","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2025-05-19T23:59:59+00:00","items":["5.02","7.01"],"status":"ready","headline":"Milestone Scientific appoints Shanth Thiyagalingam as independent director","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Appointed on May 14, 2025 as an independent director; fills Board vacancy.","Thiyagalingam is CEO of PainTEQ, a medical device maker, with prior roles at Abbott, Nevro, Stryker, and St. Jude Medical.","Brings medical device industry and commercial leadership experience to the Board."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":166826,"accession_number":"0001437749-25-012685","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2025-04-22T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Milestone Scientific replaces auditor Marcum LLP with CBIZ CPAs P.C.","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Marcum LLP resigned effective April 22, 2025; CBIZ CPAs P.C. engaged for FY ending Dec 31, 2025.","Marcum's reports on FY2023 and FY2024 financials contained no adverse opinion or modification.","No disagreements or reportable events occurred during FY2023, FY2024, or subsequent interim period.","Company did not consult CBIZ on accounting principles, audit opinions, or reportable matters before engagement.","Marcum provided a letter to SEC (Exhibit 16.1) agreeing with the disclosures."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":184231,"accession_number":"0001437749-25-000987","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2025-01-13T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Director Giandomenico Trombetta resigns from Milestone Scientific board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Giandomenico Trombetta resigned as director effective January 12, 2025, citing personal reasons and immediate matters.","Trombetta confirmed no disagreement with the company's operations, finances, policies, or practices.","No replacement has been announced; board size reduced by one member."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":200828,"accession_number":"0001437749-24-038111","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2024-12-20T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Milestone Scientific finalizes consulting agreement with ex-CEO Arjan Haverhals","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Consulting agreement with RH Consulting LLC effective Jan 1, 2025, for indefinite term.","Annual fee of $350,000: $150,000 in Q1 2025, then $66,666 per quarter thereafter.","Services include sales/business strategy, reimbursement, distributor management, and R&D guidance.","No minimum time commitment; either party may terminate with 90 days' notice.","Haverhals remains a director and retains rights under expiring employment agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":200827,"accession_number":"0001437749-24-035286","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2024-11-14T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Milestone Scientific CEO Arjan Haverhals to retire Dec 31, 2024; Chairman Neal Goldman named interim CEO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO Arjan Haverhals retires as officer on Dec 31, 2024; remains director and consultant through family company.","Chairman Neal Goldman appointed Interim CEO effective January 1, 2025; board to engage executive search for permanent CEO.","Haverhals receives modified 2024 bonus (50% cash, 50% stock vs prior 33%/67%) and $350k consulting fee for 2025.","Press release highlights recent Medicare payment rate granted for CompuFlo Epidural System under CPT code 0777T.","Haverhals says retirement not due to any disagreement with board or management."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216827,"accession_number":"0001437749-24-030130","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2024-09-27T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Milestone Scientific posts investor presentation on Sep 27; details not in filing","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Investor presentation made available on company website on September 27, 2024.","Presentation is furnished as Exhibit 99.1, but no text content is provided in this 8-K.","No new financial guidance, operational metrics, or strategic changes disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216826,"accession_number":"0001437749-24-022982","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2024-07-18T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Milestone Scientific annual meeting elects all directors, ratifies auditors","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All seven incumbent directors elected with at least 30 million shares for each; broker non-votes 20.4 million on each.","Ratification of Marcum LLP as auditors approved: 51.1M for, 0.28M against, 20k abstentions.","51.4 million shares voted (66.54% of 77.2 million outstanding).","Meeting held July 16, 2024; results reported July 18, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236556,"accession_number":"0001437749-24-011488","cik":855683,"company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","form_type":"8-K","filed_at":"2024-04-09T23:59:59+00:00","items":["1.01"],"status":"ready","headline":"Milestone Scientific nets $1.98M from selling NOLs and R&D credits to Comcast","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Received net $1,983,095 from Comcast Corporation on April 8, 2024 for unused NOLs and R&D tax credits.","Funds used for general corporate purposes and working capital; must spend only on NJ Program allowable expenses.","Company must maintain NJ headquarters for 5 years and file quarterly reports with the State of New Jersey.","Up to face value of tax credits subject to recapture if Company breaches NJ office or use-of-funds obligations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":33908940.701424345,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}